The Lumipulse G HBsAg-Quant assay for screening and quantification of the hepatitis B surface antigen
- 1 February 2016
- journal article
- research article
- Published by Elsevier in Journal of Virological Methods
- Vol. 228, 39-47
Abstract
No abstract availableKeywords
Funding Information
- China National Science and Technology (2012ZX10002003, 2012ZX10002005)
- Major Project of National Science and Technology (2012ZX09303019)
- Natural Science Foundation of China (81201339)
This publication has 34 references indexed in Scilit:
- Quantification of hepatitis B surface antigen with the novel DiaSorin LIAISON XL Murex HBsAg Quant: Correlation with the ARCHITECT quantitative assaysJournal of Clinical Virology, 2014
- False Positive Hepatitis B Surface Antigen Due to Recent VaccinationInternational Journal of Health Sciences (Qassim), 2014
- Management of patients with hepatitis B who require immunosuppressive therapyNature Reviews Gastroenterology & Hepatology, 2013
- Performance Evaluation of LUMIPULSE G1200 Autoimmunoanalyzer for the Detection of Serum Hepatitis B Virus MarkersJournal of Clinical Laboratory Analysis, 2013
- EASL Clinical Practice Guidelines: Management of chronic hepatitis B virus infectionJournal of Hepatology, 2012
- Challenges in hepatitis B detection among blood donorsCurrent Opinion in Hematology, 2011
- A new role for an old marker, HBsAgJournal of Hepatology, 2010
- Natural history of chronic hepatitis B: Special emphasis on disease progression and prognostic factorsJournal of Hepatology, 2008
- Rate of Hepatitis B Virus Infection in Pregnant Women Determined by a Monoclonal Hepatitis B Surface Antigen ImmunoassayJournal of Clinical Microbiology, 2002
- Epidemiology of hepatitis B virus infection in the Asia–Pacific regionJournal of Gastroenterology and Hepatology, 2000